NCT03610308

Brief Summary

To explore differences in patients, techniques and outcomes across the international cohort to identify areas of practice variability in the presentation and management of acute complicated calculous biliary disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 1, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2019

Completed
Last Updated

July 5, 2019

Status Verified

July 1, 2019

Enrollment Period

3 months

First QC Date

July 26, 2018

Last Update Submit

July 3, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mortality

    Overall and disease-related mortality

    60 days

Secondary Outcomes (3)

  • ICU Admission

    60 days

  • Length of hospital stay

    60 days

  • Complications

    60 days

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Pan-European, prospective audit of consecutive patients admitted for the treatment of complicated calculous biliary disease over a 30-day study period. The audit shall include unscheduled admissions from 1 October 2018 to 31 October 2018. * Commencement timeframe: The sites will start within a time window from 1 October to 31 October 2018. Following commencement, the sites will be required to include all eligible consecutive patients for 30 consecutive days. * Final date for operation inclusion: The sites can include admissions that occur up to 31 October 2018. * All patients will be followed for 60 days post-admission. Data collection should therefore be completed by 31 December 2018. * As this is an observational cohort audit, no change to normal patient management is required.

You may qualify if:

  • Adult patients (over 18 years of age) admitted for:
  • Acute gangrenous or perforated calculous cholecystitis (AAST Severity Grade II or above)
  • Choledocholithiasis or complications of cholelithiasis and/or choledocholithiasis
  • Biliary Pancreatitis
  • Procedures which should be included:
  • Cholecystectomy (open, laparoscopic or robotic)
  • Choledochotomy/common bile duct exploration (open, laparoscopic or robotic)
  • Pancreatic necrosectomy
  • Gastrojejunostomy
  • Cyst gastrostomy
  • Endoscopic retrograde choledochopancreatography (ERCP) or Endoscopic ultrasound (EUS)
  • Percutaneous cholecystostomy (transhepatic or transperitoneal)
  • Percutaneous transhepatic drainage, stone removal or stent placement

You may not qualify if:

  • Uncomplicated biliary colic
  • Biliary dyskinesia
  • Acute calculous cholecystitis (AAST Grade I)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tallaght University Hospital

Dublin, Ireland

Location

Related Publications (1)

  • Bass GA, Gillis AE, Cao Y, Mohseni S; European Society for Trauma and Emergency Surgery (ESTES) Cohort Studies Group. Patients over 65 years with Acute Complicated Calculous Biliary Disease are Treated Differently-Results and Insights from the ESTES Snapshot Audit. World J Surg. 2021 Jul;45(7):2046-2055. doi: 10.1007/s00268-021-06052-0. Epub 2021 Apr 3.

MeSH Terms

Conditions

CholangitisGallstonesCholecystitisGangrene

Condition Hierarchy (Ancestors)

Bile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesCholelithiasisCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsNecrosisPathologic Processes

Study Officials

  • Gary A Bass, MD, MSc, MBA

    Tallaght University Hospital, Dublin, Ireland

    STUDY CHAIR
  • Shahin Mohseni, MD, PhD

    Örebro University Hospital, Sweden

    PRINCIPAL INVESTIGATOR
  • Jorge Pereira, MD, FACS

    Hospital de São Teotónio, Viseu, Portugal

    PRINCIPAL INVESTIGATOR
  • Amy Gillis, MD, MCh, FRCSC

    Tallaght University Hospital, Dublin, Ireland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
60 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chair, Emergency Surgery Cohort Studies Steering Group

Study Record Dates

First Submitted

July 26, 2018

First Posted

August 1, 2018

Study Start

October 1, 2018

Primary Completion

December 31, 2018

Study Completion

January 31, 2019

Last Updated

July 5, 2019

Record last verified: 2019-07

Locations